ARTV
Artiva Biotherapeutics, Inc.
7.50$
-3.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -91.2% | -89.3% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | +0.6% | +0.0% | – | – | |
| – | -91.2% | -89.3% | – | – | – | – | – | – | – | – | – | – | |
| – | -14.6% | +0.0% | +10.6% | +9.7% | -1.5% | +28.0% | +4.7% | -1.3% | -3.6% | +13.6% | +13.5% | – | |
| – | +13.9% | +13.3% | +7.5% | +24.7% | +2.9% | +3.4% | -3.3% | +6.4% | -6.2% | +3.6% | -3.0% | – | |
| – | -9.6% | +3.0% | +9.8% | +13.2% | -0.4% | +21.4% | +2.9% | +0.4% | -4.2% | +8.4% | +13.2% | – | |
| – | -210.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -205.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -630.6% | – | – | – | – | – | – | – | – | – | – | |
| – | -206.4% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -195.7% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.